Surgery Partners, Inc.

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: US86881A1007
USD
14.44
0.13 (0.91%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
810.90
885.00
821.50
826.20
776.00
864.40
770.40
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
810.90
885.00
821.50
826.20
776.00
864.40
770.40
Raw Material Cost
689.20
732.70
665.70
670.90
650.40
664.70
643.10
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
247.40
254.40
242.80
235.20
238.60
240.70
228.40
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
70.50
66.20
73.30
66.60
73.20
65.60
64.80
Selling and Distribution Expenses
39.30
23.70
22.40
36.10
36.00
36.00
29.20
Other Expenses
-31.79
-32.06
-31.61
-30.18
-31.18
-30.63
-29.32
Total Expenditure (Excl Depreciation)
728.50
756.40
688.10
707.00
686.40
700.70
672.30
Operating Profit (PBDIT) excl Other Income
82.4
128.6
133.4
119.2
89.60000000000001
163.70000000000002
98.10000000000001
Other Income
2.90
-1.30
-10.30
9.30
-0.80
10.10
7.50
Operating Profit (PBDIT)
123.80
187.20
162.60
168.80
125.10
207.70
155.80
Interest
70.50
66.20
73.30
66.60
73.20
65.60
64.80
Exceptional Items
-18.10
-18.50
-19.00
-18.10
-15.90
-34.00
-29.90
Gross Profit (PBDT)
121.70
152.30
155.80
155.30
125.60
199.70
127.30
Depreciation
38.50
59.90
39.50
40.30
36.30
33.90
50.20
Profit Before Tax
-3.30
42.60
30.80
43.80
-0.30
74.20
10.90
Tax
-1.20
13.60
5.50
-1.10
0.00
120.80
4.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-35.90
-15.00
-22.70
-2.50
-37.70
-108.50
-31.70
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-35.90
-15.00
-22.70
-2.50
-37.70
-108.50
-31.70
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
33.80
44.00
48.00
47.40
37.40
61.90
38.10
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-2.10
29.00
25.30
44.90
-0.30
-46.60
6.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
1,688.00
1,712.90
1,729.50
1,748.30
1,740.40
1,789.70
1,896.50
Earnings per share (EPS)
-0.28
-0.12
-0.18
-0.02
-0.3
-0.86
-0.25
Diluted Earnings per share
-0.28
-0.12
-0.18
-0.02
-0.3
-0.86
-0.25
Operating Profit Margin (Excl OI)
10.16%
14.53%
16.24%
14.43%
11.55%
18.94%
12.73%
Gross Profit Margin
4.34%
11.58%
8.56%
10.18%
4.64%
12.51%
7.93%
PAT Margin
-4.43%
-1.69%
-2.76%
-0.3%
-4.86%
-12.55%
-4.11%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 4.50% vs 8.17% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is -600.00% vs -101.23% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -3.97% vs 3.11% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is -3.69% vs 18.06% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of Surgery Partners, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
810.90
5,368.00
-4,557.10
-84.89%
Other Operating Income
0.00
0.00
0.00
Total Operating income
810.90
5,368.00
-4,557.10
-84.89%
Raw Material Cost
689.20
4,486.00
-3,796.80
-84.64%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
247.40
2,174.00
-1,926.60
-88.62%
Power Cost
0
0
0.00
Manufacturing Expenses
70.50
205.00
-134.50
-65.61%
Selling and Distribution Expenses
39.30
0.00
39.30
Other Expenses
-31.79
-237.90
206.11
86.64%
Total Expenditure (Excl Depreciation)
728.50
4,486.00
-3,757.50
-83.76%
Operating Profit (PBDIT) excl Other Income
82.40
882.00
-799.60
-90.66%
Other Income
2.90
93.00
-90.10
-96.88%
Operating Profit (PBDIT)
123.80
1,204.00
-1,080.20
-89.72%
Interest
70.50
205.00
-134.50
-65.61%
Exceptional Items
-18.10
362.00
-380.10
-105.00%
Gross Profit (PBDT)
121.70
882.00
-760.30
-86.20%
Depreciation
38.50
229.00
-190.50
-83.19%
Profit Before Tax
-3.30
1,132.00
-1,135.30
-100.29%
Tax
-1.20
226.00
-227.20
-100.53%
Provisions and contingencies
0
0
0.00
Profit After Tax
-35.90
702.00
-737.90
-105.11%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-35.90
702.00
-737.90
-105.11%
Share in Profit of Associates
0
0
0.00
Minority Interest
33.80
204.00
-170.20
-83.43%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-2.10
906.00
-908.10
-100.23%
Equity Capital
0
0
0.00
Face Value
0.01
0.05
0.00
Reserves
1,688.00
4,814.00
-3,126.00
-64.94%
Earnings per share (EPS)
-0.28
8.01
-8.29
-103.50%
Diluted Earnings per share
-0.28
8.01
-8.29
-103.50%
Operating Profit Margin (Excl OI)
10.16%
16.43%
0.00
-6.27%
Gross Profit Margin
4.34%
25.35%
0.00
-21.01%
PAT Margin
-4.43%
13.08%
0.00
-17.51%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 81.09 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -8.37% vs 7.73% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 4.50% vs 8.17% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit -0.21 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -107.24% vs 14.62% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -600.00% vs -101.23% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.09 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -35.86% vs 9.02% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -3.97% vs 3.11% in Mar 2025

Quarterly - Interest
Interest 7.05 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 6.50% vs -9.69% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -3.69% vs 18.06% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.16%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025